Remdesivir for the treatment of COVID-19 — Final report

ACTT-1 Study Group Members, Essential Regulatory Documents Group Team (ERDG Team), DMID CROMS Study Information Office Team (SIO Team), Safety Oversight Committee Support Team (SOCS Team), DMID CROMS Teleconferencing Team

Research output: Contribution to journalArticlepeer-review

3538 Scopus citations

Fingerprint

Dive into the research topics of 'Remdesivir for the treatment of COVID-19 — Final report'. Together they form a unique fingerprint.

Medicine & Life Sciences